ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 355,37
1,00%
Dow Jones
42 992,21
-0,77%
DAX
19 984,32
0,74%
Brent Oil
73,44
0,00%
Bitcoin
94 246,00
0,09%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Kiora Pharmaceuticals Inc (KPRX)

  7. Kiora Pharmaceuticals Inc (KPRX) Actualités

KPRX

Kiora Pharmaceuticals (KPRX)

Kiora Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:KPRX
DateHeureSourceTitreSymboleSociété
13/11/202423h34Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:KPRXKiora Pharmaceuticals Inc
08/11/202413h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KPRXKiora Pharmaceuticals Inc
08/11/202413h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KPRXKiora Pharmaceuticals Inc
12/09/202412h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KPRXKiora Pharmaceuticals Inc
29/05/202421h47Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:KPRXKiora Pharmaceuticals Inc
28/02/202422h40Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:KPRXKiora Pharmaceuticals Inc
14/02/202422h55Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:KPRXKiora Pharmaceuticals Inc
14/02/202421h51Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:KPRXKiora Pharmaceuticals Inc
13/10/202323h09Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:KPRXKiora Pharmaceuticals Inc
01/09/202313h00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:KPRXKiora Pharmaceuticals Inc
10/08/202323h23Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KPRXKiora Pharmaceuticals Inc
21/07/202322h49Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:KPRXKiora Pharmaceuticals Inc
11/07/202323h00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:KPRXKiora Pharmaceuticals Inc
23/06/202314h35GlobeNewswire Inc.Life Science Investor Forum: Presentations Now Available for Online ViewingNASDAQ:KPRXKiora Pharmaceuticals Inc
21/06/202322h25Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KPRXKiora Pharmaceuticals Inc
20/06/202316h58GlobeNewswire Inc.Life Science Investor Forum Agenda Announced for June 22ndNASDAQ:KPRXKiora Pharmaceuticals Inc
13/06/202322h03Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:KPRXKiora Pharmaceuticals Inc
02/06/202323h09Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(1) (424b1)NASDAQ:KPRXKiora Pharmaceuticals Inc
01/06/202312h01Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:KPRXKiora Pharmaceuticals Inc
15/05/202323h28Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:KPRXKiora Pharmaceuticals Inc
09/05/202313h00Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KPRXKiora Pharmaceuticals Inc
05/05/202323h02Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:KPRXKiora Pharmaceuticals Inc
28/04/202320h20Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:KPRXKiora Pharmaceuticals Inc
23/03/202312h03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:KPRXKiora Pharmaceuticals Inc
13/02/202322h48Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:KPRXKiora Pharmaceuticals Inc
13/02/202322h40Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KPRXKiora Pharmaceuticals Inc
29/12/202212h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:KPRXKiora Pharmaceuticals Inc
22/11/202219h55TipRanksKiora Pharmaceuticals (KPRX) Receives a Hold from Maxim GroupNASDAQ:KPRXKiora Pharmaceuticals Inc
14/11/202212h25TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Kiora Pharmaceuticals (KPRX)NASDAQ:KPRXKiora Pharmaceuticals Inc
10/11/202220h05TipRanksMaxim Group Reaffirms Their Hold Rating on Kiora Pharmaceuticals (KPRX)NASDAQ:KPRXKiora Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:KPRX

Dernières Valeurs Consultées

BIT
S28753
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés